Publications and Research Notes
KEI publishes research and commentary in a variety of journals, periodicals, books and other independent publishing platforms. In-house, KEI publishes the open journal Knowledge Ecology Studies, and presents information in blogs, correspondence and reports, as well as in occasional KEI research notes and papers.
KEI Policy Briefs
KEI Research Notes
2014:1 KEI Research Note: Recent European Union Compulsory Licenses. March 1, 2014
2014:2 KEI Research Note: Recent United States Compulsory Licenses March 7, 2014
2011:2 Tedmund Wan. Survey of drug prices for 14 drugs with US government rights in patents listed in the FDA Orange Book.
2011:1. Paul Miano. Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines.
2010:4 Anne Mira Guha, Prices for Abbott's Norvir (generic name Ritonavir) as a Standalone Product in 2010.
2010:1 James Love, Comments on ACTA Provisions on Injunctions and Damages.
2008:3 Jacqueline Lee, Research and Development Related to dasatinib (Sprycel-tm).
2007:6 David Serafino. Survey of Patent Pools Demonstrates Variety of Purposes and Management Structures.
2007:2 James Love. Recent examples of the use of compulsory licenses on patents.
KEI Research Papers
2007:1. James Love and Tim Hubbard The Big Idea: Prizes to Stimulate R&D for New Medicines.
2006:1. Judit Rius Sanjuan, James Love and Robert Weissman, Protection of Pharmaceutical Test Data: A Policy Proposal.